{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:02:57Z","timestamp":1789459377056,"version":"build-2803163510"},"reference-count":48,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"BeOne Medicines, Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/03007995.2026.2686048","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:38:07Z","timestamp":1782751087000},"page":"1031-1041","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of tislelizumab\u2009+\u2009FOLFOX or CAPOX for gastric\/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison"],"prefix":"10.1080","volume":"42","author":[{"given":"Sun Young","family":"Rha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hee","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Gwang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oncology\/Hematology, Cancer Research Institute, Kyungpook National University School of Medicine","place":["Daegu, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Global Statistics and Data Science, BeOne Medicines, Ltd.","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Xu","sequence":"additional","affiliation":[{"name":"Clinical Development, BeOne Medicines, Ltd.","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_3_1","unstructured":"Ferlay JEM Lam F Laversanne M et al. Stomach factsheet. 2024. [cited 2025 Jul 04]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/7-stomach-fact-sheet.pdf"},{"key":"e_1_3_5_4_1","unstructured":"Ferlay JEM Lam F Laversanne M et al. Oesophagus factsheet. 2024. [cited 2025 Jul 04]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/6-oesophagus-fact-sheet.pdf"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2025.263"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2025.264"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078876"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2011.11.3.135"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13141-5"},{"key":"e_1_3_5_10_1","unstructured":"National Cancer Center. The cancer surveillance and monitoring project. Five-year relative survival rate by summary stage: trends in five-year relative survival rates for stomach cancer by summary stage\u2014total. 2025. [cited 2025 Aug 04]. Available from: https:\/\/www.cancerdata.re.kr\/surveillance\/en\/data?menuId=95&groupId=44&filterId=18"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104134"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.004"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.003"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000005320"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2025.25.e10"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.05.007"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00797-2"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00515-6"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13102"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2160-x"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435"},{"key":"e_1_3_5_22_1","unstructured":"BeOne. BeiGene receives 10th approval for PD-1 inhibitor tislelizumab in China. 2023. [cited 2025 Aug 01]. Available from: https:\/\/ir.beonemedicines.com\/news\/beigene-receives-10th-approval-for-pd-1-inhibitor-tislelizumab-in-china\/a92a3ed5-ae46-440e-90d2-8024a2c13930"},{"key":"e_1_3_5_23_1","unstructured":"European Medicines Agency. Tevimbra 100\u2009mg concentrate for solution for infusion. Summary of product characteristics. 2025. [cited 2025 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tevimbra-epar-product-information_en.pdf"},{"key":"e_1_3_5_24_1","unstructured":"U.S. Food and Drug Administration. TEVIMBRA (tislelizumab-jsgr) injection. Initial U.S. Approval: 2024. Highlights of prescribing information. 2025. [cited 2025 Jul 14]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761417s000lbl.pdf"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-022-01331-8"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn717"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12516"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.lba4017"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602572"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0007-7"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.28896"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1828-9"},{"key":"e_1_3_5_33_1","unstructured":"ClinicalTrials.gov. A study of DKN-01 in combination with tislelizumab\u2009\u00b1\u2009chemotherapy in patients with gastric or gastroesophageal cancer (DisTinGuish). NCT04363801. 2024. [cited 2025 Jul 02]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04363801"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00410"},{"key":"e_1_3_5_35_1","unstructured":"Leap Therapeutics. DKN-01 DeFianCe and DisTinGuish Data Update\u2014Q1 2025 Investigator Deck. 2025. [cited 2025 Jul 04]. Available from: https:\/\/investors.leaptx.com\/events\/event-details\/dkn-01-defiance-and-distinguish-data-update-q1-2025"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61420-x"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x17725740"},{"key":"e_1_3_5_38_1","unstructured":"Phillippo D Ades T Dias S et al. NICE DSU Technical Support Document 18: methods for population-adjusted indirect comparisons in submissions to NICE. (Technical support documents). 2016. [cited 2025 Jul 01]. Available from: https:\/\/research-information.bris.ac.uk\/ws\/portalfiles\/portal\/94868463\/Population_adjustment_TSD_FINAL.pdf"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01308-8"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/23814683221077643"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/mps8010013"},{"key":"e_1_3_5_42_1","unstructured":"R Core Team. R: a language and environment for statistical computing Vienna. 2021. [cited 2025 Aug 1]. Available from: https:\/\/www.R-project.org\/"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.004"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2025.25.e11"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.073"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102226"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2018.01.010"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/gidisord4030020"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.333"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2686048","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/03007995.2026.2686048","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2686048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:10:33Z","timestamp":1789456233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2026.2686048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/03007995.2026.2686048"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2026.2686048","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}